Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases
- PMID: 36243357
- DOI: 10.1016/j.arr.2022.101756
Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases
Abstract
Nuclear Factor-Erythroid Factor 2 (Nrf2) is an important transcription factor that regulates the expression of large number of genes in healthy and disease states. Nrf2 is made up of 605 amino acids and contains 7 conserved regions known as Nrf2-ECH homology domains. Nrf2 regulates the expression of several key components of oxidative stress, mitochondrial biogenesis, mitophagy, autophagy and mitochondrial function in all organs of the human body, in the peripheral and central nervous systems. Mounting evidence also suggests that altered expression of Nrf2 is largely involved in aging, neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's diseases, Amyotrophic lateral sclerosis, Stroke, Multiple sclerosis and others. The purpose of this article is to detail the essential role of Nrf2 in oxidative stress, antioxidative defense, detoxification, inflammatory responses, transcription factors, proteasomal and autophagic/mitophagic degradation, and metabolism in aging and neurodegenerative diseases. This article also highlights the Nrf2 structural and functional activities in healthy and disease states, and also discusses the current status of Nrf2 research and therapeutic strategies to treat aging and neurodegenerative diseases.
Keywords: Alzheimer’s disease; Huntington’s disease; Mitochondria; Mitochondrial biogenesis; Nuclear factor-erythroid factor 2; Oxidative stress; Parkinson’s disease.
Copyright © 2022 Elsevier B.V. All rights reserved.
Similar articles
-
Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.Pharmacol Res. 2016 Jan;103:80-94. doi: 10.1016/j.phrs.2015.11.019. Epub 2015 Nov 25. Pharmacol Res. 2016. PMID: 26626189 Review.
-
An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.Int J Mol Sci. 2021 Sep 4;22(17):9592. doi: 10.3390/ijms22179592. Int J Mol Sci. 2021. PMID: 34502501 Free PMC article. Review.
-
Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.Free Radic Biol Med. 2015 Nov;88(Pt B):253-267. doi: 10.1016/j.freeradbiomed.2015.07.147. Epub 2015 Aug 14. Free Radic Biol Med. 2015. PMID: 26281945 Free PMC article. Review.
-
The role of Nrf2 signaling in counteracting neurodegenerative diseases.FEBS J. 2018 Oct;285(19):3576-3590. doi: 10.1111/febs.14379. Epub 2018 Jan 29. FEBS J. 2018. PMID: 29323772 Free PMC article. Review.
-
Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.Mitochondrion. 2023 Jul;71:83-92. doi: 10.1016/j.mito.2023.05.007. Epub 2023 Jun 1. Mitochondrion. 2023. PMID: 37269968 Review.
Cited by
-
The Role of Antioxidant Transcription Factor Nrf2 and Its Activating Compounds in Systemic Lupus Erythematosus.Antioxidants (Basel). 2024 Oct 11;13(10):1224. doi: 10.3390/antiox13101224. Antioxidants (Basel). 2024. PMID: 39456477 Free PMC article. Review.
-
Dapagliflozin/Hesperidin Combination Mitigates Lipopolysaccharide-Induced Alzheimer's Disease in Rats.Pharmaceuticals (Basel). 2023 Sep 27;16(10):1370. doi: 10.3390/ph16101370. Pharmaceuticals (Basel). 2023. PMID: 37895841 Free PMC article.
-
A dual model of normal vs isogenic Nrf2-depleted murine epithelial cells to explore oxidative stress involvement.Sci Rep. 2024 May 13;14(1):10905. doi: 10.1038/s41598-024-60938-2. Sci Rep. 2024. PMID: 38740939 Free PMC article.
-
Electroacupuncture attenuates ferroptosis by promoting Nrf2 nuclear translocation and activating Nrf2/SLC7A11/GPX4 pathway in ischemic stroke.Chin Med. 2025 Jan 4;20(1):4. doi: 10.1186/s13020-024-01047-0. Chin Med. 2025. PMID: 39755657 Free PMC article.
-
GLSP mitigates vascular aging by promoting Sirt7-mediated Keap1 deacetylation and Keap1-Nrf2 dissociation.Theranostics. 2025 Mar 18;15(10):4345-4367. doi: 10.7150/thno.110324. eCollection 2025. Theranostics. 2025. PMID: 40225574 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical